An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic ...

Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

July 3, 2010 — A test to detect methicillin-resistant Staphylococcus aureus (MRSA) and S aureus (SA) has been recalled by the manufacturer based on an increasing number of complaints about false ...

On Monday, the U.S. Food and Drug Administration approved a new test for methicillin-resistant Staphylococcus aureus detection manufactured by Cepheid. Cepheid’s Xpert MRSA NxG test delivers ...

LONDON--(BUSINESS WIRE)--The global MRSA testing market is expected to grow at a CAGR of just above 11% during the forecast period, according to Technavio’s latest report. In this report, Technavio ...

The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) ...

Researchers have concluded MRSA screening using polymerase chain reaction generally demonstrated lower turnaround time and number of isolation days than chromogenic agar, according to research ...

Please provide your email address to receive an email when new articles are posted on . There is concern that mupirocin decolonization might cause MRSA PCR nasal swab tests to be inaccurate. A study ...

MRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant ...

SEATTLE, April 30, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global methicillin resistant Staphylococcus aureus (MRSA) testing systems market is estimated to be valued at US$ ...

Antibiotic resistance continues to push modern medicine into dangerous territory. In hospitals around the world, infections once treated easily now survive some of the strongest drugs available.

Loyola University Medical Center on Monday announced plans to start testing all incoming patients for a drug-resistant staph germ and isolating those who carry the dangerous bacteria. Subscribe to ...